Examkin

Soru

Zorluk: OrtaPediatric Endocrine Disorders

An 8-year-old girl is referred to the pediatric endocrinology clinic for evaluation of growth failure. Her parents report that she is the shortest in her class and has not needed a larger shoe size or new clothing sizes in the past two years. Review of her growth chart shows a height that has crossed two major percentile lines downward over the last 30 months, currently resting below the 1st percentile. Her weight is tracking consistently at the 45th percentile. She has no history of headaches, visual changes, gastrointestinal symptoms, or cold intolerance. Physical examination is unremarkable, with normal visual fields and Tanner stage 1 pubertal development. Arrange the following diagnostic and management steps in the most appropriate chronological order for evaluating this patient's growth deceleration.

  1. 1Assess bone age with a left hand radiograph and perform basic laboratory screening (e.g., TSH, tissue transglutaminase antibodies) to exclude systemic causes.
  2. 2Measure baseline serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor-binding protein 3 (IGFBP-3) levels.
  3. 3Perform provocative growth hormone (GH) stimulation testing to biochemically confirm GH deficiency.
  4. 4Obtain magnetic resonance imaging (MRI) of the brain and pituitary gland to rule out intracranial pathology.
  5. 5Initiate daily subcutaneous injections of recombinant human growth hormone.

Cevap

The correct sequence for evaluating pathological short stature is to first rule out systemic and thyroid conditions with basic labs and a bone age scan, followed by screening the GH axis with IGF-1, confirming GH deficiency with provocative testing, performing a pituitary MRI to identify the etiology, and finally initiating rhGH therapy.
The evaluation of pathological short stature requires a rigorous stepwise approach to avoid unnecessary, invasive, and expensive testing. Because the patient's weight is preserved while her height is dropping, an endocrine etiology (rather than malnutrition or malabsorption, which typically affects weight first) is highly suspected. However, basic screening (bone age, TSH, celiac panel) is always the first step. Once systemic causes are excluded, the GH axis is evaluated. Because random GH levels are uninterpretable due to pulsatile secretion, IGF-1 and IGFBP-3 are the initial screening markers. Low levels mandate provocative GH testing (using agents like clonidine or glucagon) to definitively diagnose deficiency. Finally, an MRI of the hypothalamic-pituitary region is required to rule out structural anomalies (like craniopharyngioma) before starting recombinant GH therapy.

Adım Adım Çözüm

1
Exclude systemic disease and evaluate bone maturation.
Normal TSH, normal celiac screen, and delayed bone age.
Growth deceleration is a non-specific sign; common non-pituitary causes (hypothyroidism, celiac disease) must be ruled out before testing the GH axis.
2
Screen the somatotropic (growth hormone) axis.
Low serum IGF-1 and IGFBP-3 levels.
GH is secreted in a pulsatile manner, so random GH levels are clinically useless. IGF-1 provides a stable marker of integrated GH secretion.
3
Confirm growth hormone deficiency.
Peak GH response below standard diagnostic thresholds during provocative testing.
IGF-1 can be falsely low due to poor nutrition. Provocative testing forces the pituitary to secrete GH; failure to do so confirms the diagnosis.
4
Identify the underlying etiology via neuroimaging.
MRI evaluates for tumors (e.g., craniopharyngioma) or congenital malformations.
rhGH therapy is contraindicated in the presence of active malignancy. Structural lesions must be ruled out once GHD is confirmed.
5
Treat the confirmed condition.
Initiation of rhGH therapy.
Definitive treatment can only begin safely after the diagnosis is biochemically proven and anatomical lesions are excluded.

Anahtar Kavram

Evaluation of pathological short stature and suspected growth hormone deficiency
Bu soruyu puanla

Konular

Pediatric Endocrine Disorders

Bu konudan daha fazla soru